MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
-34,671
-64,257
-38,707
-13,700
-16,428
Depreciation & amortization
1,345
1,257
928
655
297
Deferred income taxes
-
-
-
-
-
Stock based compensation
4,506
3,884
1,422
668
349
Change in working capital
-36,446
4,066
-5,870
43,863
6,146
Accounts receivable
1,393
325
267
-411
1,197
Inventory
-
-
-
-
-
Accounts Payable
2,483
7,375
1,335
-325
926
Other working capital
-66,390
-56,586
-43,822
30,504
-10,255
Other non-cash items
61
110
-159
102
349
Net cash provided by operating activites
-65,262
-55,216
-42,679
31,588
-9,636
Cash flows from investing activities
Investments in property, plant and equipment
-1,128
-1,370
-1,143
-1,084
-619
Acquisitions, net
-
-
-
-
-
Purchases of investments
-11,947
0
-145,701
-
0
Sales/Maturities of investments
45,500
88,565
47,220
-
0
Other investing activites
-
-
0
0
-164
Net cash used for investing activites
32,425
87,195
-99,624
-1,084
-783
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
92,591
146
68,145
-
0
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-
0
0
0
Net cash used privided by (used for) financing activities
97,901
1,064
68,597
58,259
9,960
Net change in cash
65,064
33,043
-73,706
88,763
-459
Cash at beginning of period
51,513
26,962
100,297
11,534
11,993
Cash at end of period
116,577
60,005
26,591
100,297
11,534
Free Cash Flow
Operating Cash Flow
-65,262
-55,216
-42,679
31,588
-9,636
Capital Expenditure
-1,128
-1,370
-1,143
-1,084
-619
Free Cash Flow
-66,390
-56,586
-43,822
30,504
-10,255